AstraZeneca to build US$1.5 billion cancer drug plant in Singapore, reduce industry’s reliance on China
AstraZeneca plans to build a US$1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish drug maker said on Monday. …